---
figid: PMC2242658__bcr1769-8
figtitle: Wingless and integration site growth factor (WNT)-induced epidermal growth
  factor receptor (EGFR) transactivation
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Equus caballus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Armoracia rusticana
- Xenopus laevis
- Retroviral vector pLNCX
pmcid: PMC2242658
filename: bcr1769-8.jpg
figlink: /pmc/articles/PMC2242658/figure/F8/
number: F8
caption: Schematic representation of wingless and integration site growth factor (WNT)-induced
  epidermal growth factor receptor (EGFR) transactivation. Our results show that Wnt1
  induces a signaling cascade that links the activation of EGFR in a manner dependent
  on Dishevelled, SRC, metalloprotease, and EGF-like ligand to the sFRP1-sensitive
  activation of Frizzled receptors. The activation of EGFR, which may occur via phosphorylation
  of Y845, an SRC phosphorylation site, triggers activation of the extracellular signal-regulated
  kinase 1/2 (ERK1/2) pathway. Together with the canonical WNT/β-catenin pathway and
  its target genes, including c-Myc, the ERK1/2 pathway promotes proliferation and
  survival of breast cancer cells. Furthermore, activation of the ERK1/2 signaling
  by Wnt1 may contribute to the development of anti-estrogen resistance. DVL, Dishevelled;
  EGF, epidermal growth factor; ER, estrogen receptor; sFRP1, secreted Frizzled-related
  protein 1.
papertitle: Autocrine WNT signaling contributes to breast cancer cell proliferation
  via the canonical WNT pathway and EGFR transactivation.
reftext: Thomas Schlange, et al. Breast Cancer Res. 2007;9(5):R63-R63.
year: '2007'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9571726
figid_alias: PMC2242658__F8
figtype: Figure
organisms_ner:
- Mus musculus
- Bos taurus
- Capra hircus
- Equus caballus
- Homo sapiens
- Oryctolagus cuniculus
redirect_from: /figures/PMC2242658__F8
ndex: 12ca468d-dee3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2242658__bcr1769-8.html
  '@type': Dataset
  description: Schematic representation of wingless and integration site growth factor
    (WNT)-induced epidermal growth factor receptor (EGFR) transactivation. Our results
    show that Wnt1 induces a signaling cascade that links the activation of EGFR in
    a manner dependent on Dishevelled, SRC, metalloprotease, and EGF-like ligand to
    the sFRP1-sensitive activation of Frizzled receptors. The activation of EGFR,
    which may occur via phosphorylation of Y845, an SRC phosphorylation site, triggers
    activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway.
    Together with the canonical WNT/β-catenin pathway and its target genes, including
    c-Myc, the ERK1/2 pathway promotes proliferation and survival of breast cancer
    cells. Furthermore, activation of the ERK1/2 signaling by Wnt1 may contribute
    to the development of anti-estrogen resistance. DVL, Dishevelled; EGF, epidermal
    growth factor; ER, estrogen receptor; sFRP1, secreted Frizzled-related protein
    1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sfrp1
  - Wnt1
  - Dvl1
  - Egfr
  - Src
  - Ctnnb1
  - Mapk3
  - Mapk1
  - Myc
  - Nol3
  - SFRP1
  - WNT1
  - EGFR
  - SRC
  - CTNNB1
  - MAPK3
  - MAPK1
  - MYC
  - CTNND1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - FGR
  - FYN
  - YES1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - Tamoxifen
  - Cancer
---
